Broad-spectrum neutralization capability against authentic SARS-CoV-2. Neutralization antibody titers of aVHH-11-Fc, aVHH-13-Fc, and aVHH-14-Fc for SARS-CoV-2 BMA8, prototype, Delta, Omicron BA.1 and Omicron BA.2. Briefly, neutralization titer was detected by authentic SARS-CoV-2. Nbs were successively diluted dilution in a two-fold scale and 100 TCID50 SARS-CoV-2 were added. Post incubation, cells were added. The maximum antibody dilution concentrations that neutralize all viral CPE were defined as the neutralizing titer. Statistical analysis was performed by two-way ANOVA, ∗P < 0.05. Data were presented as mean with standard deviation.